Page last updated: 2024-10-18

histamine and Minimal Disease, Residual

histamine has been researched along with Minimal Disease, Residual in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Histamine levels were measured serially in whole blood samples before and during imatinib therapy in 80 CML patients by radioimmunoassay."1.34Clinical and prognostic significance of histamine monitoring in patients with CML during treatment with imatinib (STI571). ( Agis, H; Esterbauer, H; Geissler, K; Haas, OA; Herndlhofer, S; Jäger, U; Mannhalter, C; Pirc-Danoewinata, H; Semper, H; Sillaber, C; Sperr, WR; Valent, P, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agis, H1
Sperr, WR1
Herndlhofer, S1
Semper, H1
Pirc-Danoewinata, H1
Haas, OA1
Mannhalter, C1
Esterbauer, H1
Geissler, K1
Sillaber, C1
Jäger, U1
Valent, P1

Other Studies

1 other study available for histamine and Minimal Disease, Residual

ArticleYear
Clinical and prognostic significance of histamine monitoring in patients with CML during treatment with imatinib (STI571).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:11

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Benzamides; Biomarkers; Cohort Studies; Dose-R

2007